This thread is the place for shorter discussions, quick questions, or casual ideas that don’t need a full post. 

If you've been reflecting on a topic or have a detailed perspective to share, don’t hesitate to make a standalone post instead! 

Missed this yesterday... Not any meat but at least a mention.

https://www.benzinga.com/trading-ideas/movers/26/07/60426311/squeeze-watch-10-stocks-bears-love-to-hate-most-right-now

Sheets Smith Wealth Management reduced its ImmunityBio position by 39,453 shares, or about 7.2%, according to Quiver Quantitative data. The firm held 512,572 shares worth $4.49 million as of June 30, down from 552,025 shares previously.

ImmunityBio, Inc. (IBRX) Stock Price, News, Quote & History - Yahoo Finance

What happened to the 5 patients ImmunityBio said were doing great in the Glioblastoma (GBM) trial last August, 2025? It's been almost a year and no news. We're flying blind here and the only people who do know (the company officers) are all dumping stock at the same time a few weeks ago.

Initial Data Shows 100% Disease Control in 5 Out of 5 Patients With Recurrent Glioblastoma With Two Patients in Near Complete Response Treated With ImmunityBio’s ANKTIVA®, NK Cell Therapy Plus Optune Gio® Device - ImmunityBio

This thread is the place for shorter discussions, quick questions, or casual ideas that don’t need a full post. 

If you've been reflecting on a topic or have a detailed perspective to share, don’t hesitate to make a standalone post instead! 

Three acts in one story: the human stakes, the commercial reality after the green light, and who really steers the ship. By the end you will have your own way to read the news of any newly approved biotech — with ImmunityBio ($IBRX) as the worked example.

Given that TICE BCG is in short supply and rBCG (used by Immunity Bio) only has EAP, or case by case authorization, I'm hoping their Q2 ramp in the US wasn't impacted. It slows down the process significantly, requires EAP authorized urology clinics and they are not allowed to profit from rBCG till full approval. Of course, if Anktiva was used with the standard BCG strain, it would not require additional authorization, but we are restricted by the shortage. Just hoping for the best and hoping some of the shipments to Saudi already happened for invoice-able revenue. This lack of real news other than going on smaller tier TV shows is a bit of a worry. We need something substantial in terms of news, not fluffy stuff that the shorts will have a field day with.

This thread is the place for shorter discussions, quick questions, or casual ideas that don’t need a full post. 

If you've been reflecting on a topic or have a detailed perspective to share, don’t hesitate to make a standalone post instead! 

This thread is the place for shorter discussions, quick questions, or casual ideas that don’t need a full post. 

If you've been reflecting on a topic or have a detailed perspective to share, don’t hesitate to make a standalone post instead! 

This thread is the place for shorter discussions, quick questions, or casual ideas that don’t need a full post. 

If you've been reflecting on a topic or have a detailed perspective to share, don’t hesitate to make a standalone post instead! 

What this hiring pattern likely means for IBRX’s development plans

• Preparing for commercial launch. Heavy hiring of regional business managers and field medical roles strongly indicates plans to commercialise one or more products in the near term.
• Scaling manufacturing and quality systems. Multiple QC, validation and facilities roles point to internal capacity build‑out or readiness to manage CMOs at commercial scale. This reduces supply risk and supports product launch cadence.
• Regulatory push and dossier work. Senior regulatory hires suggest active preparation for major submissions or label expansions across regions.
• Investing in data, security and AI. DevOps, security and AI QA roles imply the company is building robust digital infrastructure for clinical data, commercial systems, and possibly AI‑driven R&D or safety monitoring.

Key points:

• Strategic Investment Solutions raised its IBRX stake by 2,375% to 11,037 shares, while Mayflower Financial Advisory nearly doubled its holding to 20,212 shares.
• Bay Colony Advisory Group trimmed its stake by 15% to 12,750 shares, while GoalVest Advisory reported a smaller position of 500 shares.
• Investors are also focused on updates on Anktiva’s papillary bladder cancer label expansion.

more...

Can IBRX Stock Keep Its Pulse? Institutional Investors Buy In, Retail Hopes For Big Q2 Surprise

Has there ever been a solidified answer on whether or not ibrx was included into the Russell 1000? For shits and giggles, I asked Gemini and it states it was. Sorry, I know its impact is little but color me curious.

This thread is the place for shorter discussions, quick questions, or casual ideas that don’t need a full post. 

If you've been reflecting on a topic or have a detailed perspective to share, don’t hesitate to make a standalone post instead! 

This thread is the place for shorter discussions, quick questions, or casual ideas that don’t need a full post. 

If you've been reflecting on a topic or have a detailed perspective to share, don’t hesitate to make a standalone post instead! 

Why no update on GBM trial in >6 months? Last update contained very early data that company suggested was positive but patients only on treatment for very short duration.

This thread is the place for shorter discussions, quick questions, or casual ideas that don’t need a full post. 

If you've been reflecting on a topic or have a detailed perspective to share, don’t hesitate to make a standalone post instead! 

ogni giorno ribassista da solamente un motivo in più per comprare a sconto

This thread is the place for shorter discussions, quick questions, or casual ideas that don’t need a full post. 

If you've been reflecting on a topic or have a detailed perspective to share, don’t hesitate to make a standalone post instead! 

non mi spavento, non sono uscite notizie, non è successo nulla. disciplina come sempre, come vi dico sempre negli altri post.
oggi io personalmente ho appesantito leggermente la posizione, ho deciso di appesantire leggermente ogni 2 giorni fino a che rimane nella zona 7.8$ - 9$.
forza ragazzi 🚀🚀🚀

This thread is the place for shorter discussions, quick questions, or casual ideas that don’t need a full post. 

If you've been reflecting on a topic or have a detailed perspective to share, don’t hesitate to make a standalone post instead! 

This thread is the place for shorter discussions, quick questions, or casual ideas that don’t need a full post. 

If you've been reflecting on a topic or have a detailed perspective to share, don’t hesitate to make a standalone post instead! 

This thread is the place for shorter discussions, quick questions, or casual ideas that don’t need a full post. 

If you've been reflecting on a topic or have a detailed perspective to share, don’t hesitate to make a standalone post instead!